Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulbrich

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Biophysical Journal|February 13, 2001
Poly[N-(2-hydroxypropyl)methacrylamide] polymers diffuse in brain extracellular space with same tortuosity as small moleculesS Prokopová-Kubinová, L Vargová, L Tao, et al.
Cell Transplantation|February 3, 2017
SYNTHETIC POLYMER MATRICES FOR NEURAL CELL TRANSPLANTATIONS Woerly, K Ulbrich, V Chytry, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierL W Seymour, Y Miyamoto, H Maeda, et al.
Human Gene Therapy|November 10, 1996
Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymersM A Wolfert, E H Schacht, V Toncheva, et al.
Molecular Pharmaceutics|June 8, 2010
Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bondB Ríhová, T Etrych, M Sírová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomesB Ríhová, T Etrych, M Pechar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitroM Kovár, L Kovár, V Subr, et al.
British Journal of Cancer|October 1, 1994
Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanomaL W Seymour, K Ulbrich, P S Steyger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2008
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targetingP Chytil, T Etrych, C Konák, et al.
Bratislavske Lekarske Listy|November 12, 1998
[Use of targeted drugs in antineoplastic and immunosuppressive therapy]B Ríhová, J Trohalm, M Jelínková, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Biophysical Journal|February 13, 2001
Poly[N-(2-hydroxypropyl)methacrylamide] polymers diffuse in brain extracellular space with same tortuosity as small moleculesS Prokopová-Kubinová, L Vargová, L Tao, et al.
Cell Transplantation|February 3, 2017
SYNTHETIC POLYMER MATRICES FOR NEURAL CELL TRANSPLANTATIONS Woerly, K Ulbrich, V Chytry, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierL W Seymour, Y Miyamoto, H Maeda, et al.
Human Gene Therapy|November 10, 1996
Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymersM A Wolfert, E H Schacht, V Toncheva, et al.
Molecular Pharmaceutics|June 8, 2010
Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bondB Ríhová, T Etrych, M Sírová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomesB Ríhová, T Etrych, M Pechar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitroM Kovár, L Kovár, V Subr, et al.
British Journal of Cancer|October 1, 1994
Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanomaL W Seymour, K Ulbrich, P S Steyger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2008
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targetingP Chytil, T Etrych, C Konák, et al.
Bratislavske Lekarske Listy|November 12, 1998
[Use of targeted drugs in antineoplastic and immunosuppressive therapy]B Ríhová, J Trohalm, M Jelínková, et al.
Pageof 10